While recent studies could not detect a predisposition for leukemia based on presence or absence of particular inhibitory and stimulatory KIR genes or KIR haplotype classification, there is growing evidence for beneficial effects of KIR B genotype donors in HSCT for AML. The gene discussed is KIR3DL1; the disease is acute myeloid leukemia.